These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 163566)
1. Dissociation of in vivo and in vitro "autonomy" in human adrenocortical tumour. Voigt KH; Fehm HL; Pfeiffer EF Acta Endocrinol (Copenh); 1975 Feb; 78(2):302-5. PubMed ID: 163566 [TBL] [Abstract][Full Text] [Related]
2. Correlation of alkaline phosphatase staining of cortisol-producing adrenocortical tumors with dexamethasone suppression and ACTH stimulation. Aiba M Acta Pathol Jpn; 1977 Nov; 27(6):877-91. PubMed ID: 204155 [TBL] [Abstract][Full Text] [Related]
3. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy. Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560 [TBL] [Abstract][Full Text] [Related]
4. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies. Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012 [TBL] [Abstract][Full Text] [Related]
5. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland. Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930 [TBL] [Abstract][Full Text] [Related]
6. An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells. Rácz K; Fehér J; Csomós G; Varga I; Kiss R; Gláz E J Endocrinol; 1990 Feb; 124(2):341-5. PubMed ID: 2155989 [TBL] [Abstract][Full Text] [Related]
7. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. Chabre O; Liakos P; Vivier J; Chaffanjon P; Labat-Moleur F; Martinie M; Bottari SP; Bachelot I; Chambaz EM; Defaye G; Feige JJ J Clin Endocrinol Metab; 1998 Sep; 83(9):3134-43. PubMed ID: 9745416 [TBL] [Abstract][Full Text] [Related]
8. Cyclic Cushing's syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma. Terzolo M; Alì A; Pia A; Bollito E; Reimondo G; Paccotti P; Scardapane R; Angeli A J Endocrinol Invest; 1994 Dec; 17(11):869-74. PubMed ID: 7745235 [TBL] [Abstract][Full Text] [Related]
9. In vitro synthesis of steroids by a feminising adrenocortical carcinoma: effect of prolactin and other protein hormones. Millington DS; Golder MP; Cowley T; London D; Roberts H; Butt WR; Griffiths K Acta Endocrinol (Copenh); 1976 Jul; 82(3):561-71. PubMed ID: 180740 [TBL] [Abstract][Full Text] [Related]
10. Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia. Lamberts SW; Bons EG; Bruining HA J Clin Endocrinol Metab; 1984 Jun; 58(6):1106-10. PubMed ID: 6327752 [TBL] [Abstract][Full Text] [Related]
11. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Hensen J; Buhl M; Bähr V; Oelkers W Klin Wochenschr; 1990 Jun; 68(12):608-14. PubMed ID: 2165544 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and preclinical aspects of adrenal Cushing syndrome]. Ambrosi B; Re T; Passini E; Peverelli S; Sartorio A; Colombo P Minerva Endocrinol; 1995 Mar; 20(1):39-47. PubMed ID: 7651281 [TBL] [Abstract][Full Text] [Related]
13. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome. Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900 [TBL] [Abstract][Full Text] [Related]
14. Studies of ACTH secretion control in 116 cases of Cushing's syndrome. Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970 [TBL] [Abstract][Full Text] [Related]
15. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome. Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270 [TBL] [Abstract][Full Text] [Related]
16. [Similarity and differences of the pathogenesis of Itsenko-Cushing syndrome variants]. Baranov VG; Nechaĭ AI; Trofimov VM; Savushkina AS; Kalashnikov SA Probl Endokrinol (Mosk); 1986; 32(6):3-11. PubMed ID: 3027692 [TBL] [Abstract][Full Text] [Related]
17. CRH in Cushing's syndrome. Müller OA; Stalla GK; von Werder K Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Aron DC; Raff H; Findling JW J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382 [TBL] [Abstract][Full Text] [Related]